The seroprevalence of SARS-CoV-2 infection in Malaysia: 7 August to 11 October 2020.

ABSTRACT:

Background

From the beginning of the COVID-19 pandemic until mid-October 2020, Malaysia recorded ~15,000 confirmed cases. But there could be undiagnosed cases due mainly to asymptomatic infections. Seroprevalence studies can better quantify underlying infection from SARS-CoV-2 by identifying humoral antibodies against the virus. This study was the first to determine the prevalence of SARS-CoV-2 infection in  Malaysia's general population, as well as the proportion of asymptomatic and undiagnosed infections.

Methods

This cross-sectional seroprevalence study with a two-stage stratified random cluster sampling design included 5,131 representative community dwellers in Malaysia aged ≥1 year. Data collection lasted from 7 August to 11 October 2020 involving venous blood sampling

SUBMITTER: Chong ZL 

PROVIDER: S-EPMC10542612 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature